Bibliographie du CRMR

Éditorial - Maladie(s) de Castleman.

Oksenhendler E. .

Rev Med Interne. 2022 Dec;43(10S1):10S1-10S3.

Maladies de Castleman : épidémiologie, classification et critères diagnostiques.

Bertinchamp R, Terriou L.

Rev Med Interne. 2022 Dec;43(10S1):10S4-10S9.

La maladie de Castleman : aspects anatomopathologiques.

Meignin V, Parrens M.

Rev Med Interne. 2022 Dec;43(10S1):10S10-10S16.

Diagnostics différentiels de la maladie de Castleman.

Viallard JF, Roriz M, Parrens M, Bonnotte B.

Rev Med Interne. 2022 Dec;43(10S1):10S17-10S25.

Approche thérapeutique des maladies de Castleman : l’émergence des thérapies ciblées.

Galicier L, Schleinitz N.

Rev Med Interne. 2022 Dec;43(10S1):10S26-10S33.

Characteristics of circulating KSHV-infected viroblasts during active KSHV+ multicentric Castleman disease.

Martin de Fremont G, Vanjak A, Sbihi Z, Knapp S, Garzaro M, Chbihi M, Fournier B, Poirot J, Dossier A, Silvestrini MA, Villemonteix J, Meignin V, Galicier L, Bertinchamp R, Le Goff J, Salmona M, Flamarion E, Cassius C, Lebbé C, Ronchetti AM, Latour S, Oksenhendler E, Carcelain G, Boutboul D.

Blood Adv. 2022 Dec 12:bloodadvances.2022008456.

Leg-type form of idiopathic multicentric Castleman disease associated with severe lower extremity chronic venous/lymphatic disease.

Ballul T, Belfeki N, de Masson A, Meignin V, Woerther PL, Martin A, Poullot E, Wargnier A, Fadlallah J, Garzaro M, Malphettes M, Fieschi C, Maisonobe L, Bensekhri H, Guillot H, Bertinchamp R, Jachiet M, Poirot J, Galicier L, Oksenhendler E, Boutboul D.

EJHaem. 2021 Dec 23;3(1):175-179.

Characteristics of thrombocytopenia, anasarca, fever, reticulin fibrosis and organomegaly syndrome: a retrospective study from a large Western cohort.

Maisonobe L, Bertinchamp R, Damian L, Gérard L, Berisha M, Guillet S, Fieschi C, Malphettes M, Fadlallah J, Hié M, Dunogué B, De Wilde V, Vandergeynst F, Zafrani L, Grall M, Saada N, Garzaro M, Oksenhendler E, Galicier L, Boutboul D.

Br J Haematol. 2021 Sep 28

Validated international definition of the thrombocytopenia, anasarca, fever, reticulin fibrosis, renal insufficiency, and organomegaly clinical subtype (TAFRO) of idiopathic multicentric Castleman disease.

Nishimura Y, Fajgenbaum DC, Pierson SK, Iwaki N, Nishikori A, Kawano M, Nakamura N, Izutsu K, Takeuchi K, Nishimura MF, Maeda Y, Otsuka F, Yoshizaki K, Oksenhendler E, van Rhee F, Sato Y.

Am J Hematol. 2021 Oct 1;96(10):1241-1252

Autoimmune hypoglycemia expands the biological spectrum of HHV8+ multicentric Castleman disease.

Arnautou P, Auclair M, Fellahi S, Bouché C, Fieschi C, Barrak E, Queyrel-Moranne V, Chaillous L, Blin N, Malphettes M, Fadlallah J, Bertinchamp R, Gérard L, Bengoufa D, Galicier L, Oksenhendler E, Vigouroux C, Boutboul D.

Blood Adv. 2021 Apr 13;5(7):1848-1852.

JAK1/2 Inhibition in Severe TAFRO Syndrome: A Case Report.

Killian M, Viel S, Chalayer E, Forest F, Grange S, Bonnefoy PB, Oksenhendler E, Cathébras P, Paul S.

Ann Intern Med. 2021 Jan 12. doi: 10.7326/L20-1051. Online ahead of print.

ACCELERATE: A Patient-Powered Natural History Study Design Enabling Clinical and Therapeutic Discoveries in a Rare Disorder.

Pierson SK, Khor JS, Ziglar J, Liu A, Floess K, NaPier E, Gorzewski AM, Tamakloe MA, Powers V, Akhter F, Haljasmaa E, Jayanthan R, Rubenstein A, Repasky M, Elenitoba-Johnson K, Ruth J, Jacobs B, Streetly M, Angenendt L, Patier JL, Ferrero S, Zinzani PL, Terriou L, Casper C, Jaffe E, Hoffmann C, Oksenhendler E, Fosså A, Srkalovic G, Chadburn A, Uldrick TS, Lim M, van Rhee F, Fajgenbaum DC.

Cell Rep Med. 2020 Dec 22;1(9):100158.

International evidence-based consensus diagnostic and treatment guidelines for unicentric Castleman disease.

van Rhee F, Oksenhendler E, Srkalovic G, Voorhees P, Lim M, Dispenzieri A, Ide M, Parente S, Schey S, Streetly M, Wong R, Wu D, Maillard I, Brandstadter J, Munshi N, Bowne W, Elenitoba-Johnson KS, Fössa A, Lechowicz MJ, Chandrakasan S, Pierson SK, Greenway A, Nasta S, Yoshizaki K, Kurzrock R, Uldrick TS, Casper C, Chadburn A, Fajgenbaum DC.

Blood Adv. 2020 Dec 8;4(23):6039-6050.

Insufficient evidence exists to use histopathologic subtype to guide treatment of idiopathic multicentric Castleman disease.

Fajgenbaum DC, Wu D, Goodman A, Wong R, Chadburn A, Nasta S, Srkalovic G, Mukherjee S, Leitch H, Jayanthan R, Ferrero S, Sato Y, Schey S, Dispenzieri A, Oksenhendler E, Zinzani PL, Lechowicz MJ, Hoffmann C, Pemmaraju N, Bagg A, Fossa A, Lim MS, van Rhee F; Castleman Disease Collaborative Network Scientific Advisory Board diagnostic criteria international working group and treatment guidelines international working group.

Am J Hematol. 2020 Sep 7.

A Novel Predictive Model for Idiopathic Multicentric Castleman Disease: The International Castleman Disease Consortium Study.

Yu L, Shi M, Cai Q, Strati P, Hagemeister F, Zhai Q, Li L, Fang X, Li J, Sun R, Zhang S, Yang H, Wang Z, Qian W, Iwaki N, Sato Y, Zhang L, Li J, Oksenhendler E, Xu-Monette ZY, Young KH.

Oncologist. 2020 Aug 27

The French paediatric cohort of Castleman disease: a retrospective report of 23 patients.

Borocco C, Ballot-Schmit C, Ackermann O, Aladjidi N, Delaleu J, Giacobbi-Milet V, Jannier S, Jeziorski E, Maurier F, Perel Y, Piguet C, Oksenhendler E, Koné-Paut I, Galeotti C.

Orphanet J Rare Dis. 2020

Epidemiology of Castleman disease associated with AA amyloidosis: description of 2 new cases and literature review.

Fayand A, Boutboul D, Galicier L, Kahn JE, Buob D, Boffa JJ, Cez A, Oksenhendler E, Grateau G, Ducharme-Bénard S, Georgin-Lavialle S.

Amyloid. 2019 Jul 31:1-6. [Epub ahead of print]

Treatment and out come of Unicentric Castleman Disease: a retrospective analysis of 71 cases.

Boutboul D, Fadlallah J, Chawki S, Fieschi C, Malphettes M, Dossier A, Gérard L, Mordant P, Meignin V, Oksenhendler E, Galicier L.

Br J Haematol. 2019 Jul;186(2):269-273.

Kaposi's sarcoma-associated herpesvirus/human herpesvirus 8 associated lymphoproliferative disorders.

Oksenhendler E, Boutboul D, Galicier L.

Blood. 2019 Jan 4.

International, evidence-based consensus treatment guidelines for idiopathic multicentric Castleman disease.

van Rhee F, Voorhees P, Dispenzieri A, Fosså A, Srkalovic G, Ide M, Munshi N, Schey S, Streetly M, Pierson SK, Partridge HL, Mukherjee S, Shilling D, Stone K, Greenway A, Ruth J, Lechowicz MJ, Chandrakasan S, Jayanthan R, Jaffe ES, Leitch H, Pemmaraju N, Chadburn A, Lim MS, Elenitoba-Johnson KS, Krymskaya V, Goodman A, Hoffmann C, Zinzani PL, Ferrero S, Terriou L, Sato Y, Simpson D, Wong R, Rossi JF, Nasta S, Yoshizaki K, Kurzrock R, Uldrick TS, Casper C, Oksenhendler E, Fajgenbaum DC.

Blood. 2018 Nov 15;132(20):2115-2124. Epub 2018 Sep 4. Review.

The full spectrum of Castleman disease: 273 patients studied over 20 years.

Oksenhendler E, Boutboul D, Fajgenbaum D, Mirouse A, Fieschi C, Malphettes M, Vercellino L, Meignin V, Gérard L, Galicier L.

Br J Haematol. 2018 Jan;180(2):206-216

Inter national, evidence-based consensus diagnostic criteria for HHV-8-negative/idiopathic multicentric Castleman disease.

Fajgenbaum DC, Uldrick TS, Bagg A, Frank D, Wu D, Srkalovic G, Simpson D, Liu AY, Menke D, Chandrakasan S, Lechowicz MJ, Wong RS, Pierson S, Paessler M, Rossi JF, Ide M, Ruth J, Croglio M, Suarez A, Krymskaya V, Chadburn A, Colleoni G, Nasta S, Jayanthan R, Nabel CS, Casper C, Dispenzieri A, Fosså A, Kelleher D, Kurzrock R, Voorhees P, Dogan A, Yoshizaki K, van Rhee F, Oksenhendler E, Jaffe ES, Elenitoba-Johnson KS, Lim MS.

Blood. 2017 Mar 23;129(12):1646-1657.

iNKT and memory B-cell alterations in HHV-8 multicentric Castleman disease.

Sbihi Z, Dossier A, Boutboul D, Galicier L, Parizot C, Emarre A, Hoareau B, Dupin N, Marcelin AG, Oudin A, Fieschi C, Agbalika F, Autran B, Oksenhendler E, Carcelain G. Blood. 2017 Feb 16;129(7):855-865.

Autoimmune thrombotic thrombocytopenic purpura associated with HHV8-related Multicentric Castleman disease.

London J, Boutboul D, Agbalika F, et al. Br J Haematol. 2016 May 25. [Epub ahead of print]

Human herpesvirus 8+ polyclonal IgMλ B-cell lymphocytosis mimicking plasmablastic leukemia/lymphoma in HIV-infected patients.

Oksenhendler E, Boutboul D, Beldjord K, et al. Eur J Haematol. 2013 Dec;91(6):497-503.

Prospective study of rituximab in chemotherapy-dependent human immunodeficiency virus associated multicentric Castleman's disease: ANRS 117 CastlemaB Trial.

Gérard L, Bérezné A, Galicier L, et al. J Clin Oncol. 2007 Aug 1;25(22):3350-6.

Thoracic radiographic and CT findings of multicentric Castleman disease in HIV-infected patients.

Guihot A, Couderc LJ, Rivaud E, et al. J Thorac Imaging. 2007 May;22(2):207-11. Review.

Pulmonary manifestations of multicentric Castleman's disease in HIV infection: a clinical, biological and radiological study.

Guihot A, Couderc LJ, Agbalika F, et al. Eur Respir J. 2005 Jul;26(1):118-25.

Failure of cidofovir in HIV-associated multicentric Castleman disease.

Berezne A, Agbalika F, Oksenhendler E. Blood. 2004 Jun 1;103(11):4368-9

HHV8-related non-Hodgkin's lymphoma of the spermatic cord in a patient with HIV-associated multicentric Castleman disease.

Boulanger E, Brière J, Gaulard P, Droz D, Oksenhendler E. Am J Hematol. 2003 Jan;72(1):70-1.

High incidence of Kaposi sarcoma-associated herpesvirus-related non-Hodgkin lymphoma in patients with HIV infection and multicentric Castleman disease.

Oksenhendler E, Boulanger E, Galicier L, et al. Blood. 2002 Apr 1;99(7):2331-6.

Castleman's disease and lymphoma: report of eight cases in HIV-negative patients and literature review.

Larroche C, Cacoub P, Soulier J, et al. Am J Hematol. 2002 Feb;69(2):119-26. Review.

Kaposi sarcoma-associated herpesvirus infects monotypic (IgM lambda) but polyclonal naive B cells in Castleman disease and associated lymphoproliferative disorders.

Du MQ, Liu H, Diss TC, et al. Blood. 2001 Apr 1;97(7):2130-6.

High levels of human herpesvirus 8 viral load, human interleukin-6, interleukin-10, and C reactive protein correlate with exacerbation of multicentric castleman disease in HIV-infected patients.

Oksenhendler E, Carcelain G, Aoki Y, et al. Blood. 2000 Sep 15;96(6):2069-73.

CDCN expert

Voir la vidéo sur youtube

Forum Broadcast on Castleman Disease

Voir le forum